Vincerx Pharma, Inc.

UBS Group AG VINC
Report date
12/31/2024
Quarter
2024 Q4
Filed
2/14/2025
Shares
92,779
Value ($000)
24
Weight
0.0%
2022 Q3 - 2024 Q4 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).